FDG (Fludeoxyglucose [18F])

This medicinal product is for diagnostic use only. Fludeoxyglucose (18F) is intended for use with positron emission tomography (PET) for adults and children.

Delivered to
Questions about expiration date & durability?

Description

Therapeutic indications

The radiopharmaceutical is intended for imaging in patients undergoing oncological diagnostics, in order to describe function or diseases where increased glucose influx in specific target organs or tissues with increased glucose uptake.

Oncology

Diagnosis:

  • Characterisation of solitary pulmonary nodule
  • Detection of cancer of unknown origin, revealed for example by cervical adenopathy, liver or bones metastases
  • Characterisation of a pancreatic mass

Cardiology

In the cardiologic indication, the diagnostic target is viable myocardial tissue that takes up glucose but is hypo-perfused, as it must be assessed beforehand using appropriate bloodflow imaging techniques.

  • Evaluation of myocardial viability in patients with severe impaired left ventricular function who are candidates for revascularisation when conventional imaging modalities are not contributive.

Neurology

In the neurologic indication the interictal glucose hypometabolism is the diagnostic target.

  • Localisation of epileptogenic foci in the presurgical evaluation of partial temporal epilepsy

The uptake of 18F-FDG by tissues is a marker for the tissue uptake of glucose, which in turn is closely correlated with certain types of tissue metabolism. After 18F-FDG is injected into a patient, a PET scanner can form two-dimensional or three-dimensional images of the distribution of 18F-FDG within the body.


Fact about the product

SAM Nordic delivers FDG from the cyclotron in Berlin, via Life Radiopharma. SAM Nordic may assist in case of urgent deliveries. Deliveries of FDG can be made all weekdays and Saturdays. The product is available for distribution to the Swedish hospitals only.

Fludeoxyglucose (18F) Life Radiopharma 300 MBq/ml – 3100 MBq/ml, solution for injection.

FDG (Fludeoxyglucose [18F]) is manufactured by Life Radiopharma and is distributed in Sweden by SAM Nordic.


Information for HCP

Follow the link to find your local SmPC

Link to SmPC in Sweden